Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
Venetoclax plus lage dosis cytarabine bij therapienaïeve patiënten met AML
jul 2019 | Leukemie